Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
Become a Member | Sign in
Home>News>This Article

Scientists Engineer Human Stem Cells and Move Closer to Mastering Regenerative Medicine

Published: Wednesday, December 11, 2013
Last Updated: Wednesday, December 11, 2013
Bookmark and Share
Researchers have successfully converted human embryonic stem cells (hESCs) cultured in the laboratory to a state that is closer to the cells found in the human blastocyst.

This means that scientists are one step closer to cultivating stem cells for research and potential therapeutic purposes, as well as understanding the processes of early human development. These findings are published in the current issue of the prestigious science journal Cell Stem Cell.

Pluripotent stem cells such as hESCs and induced pluripotent stem cells (iPSCs) have the remarkable ability to differentiate into various cell types of the adult body while proliferating continuously in culture. In the field of regenerative medicine, these cells are potentially a limitless resource to generate cells of different body parts such as the eye, liver, brain, kidney and pancreas to treat degenerative diseases or replace of worn out organs. Pluripotency is the essential property of the cells of the blastocyst in the early stages of human development. However, when cultured in the laboratory, these cells adopt molecular differences, which limit their use in therapeutic applications or disease modeling.

Using previously established hESCs, the researchers screened for culture conditions that could induce a stable change of cell state. They found that the use of a specific combination of small molecules and growth factors, termed 3iL, converted hESCs to a state that resembled cells within the native blastocysts.

The GIS team’s discovery will empower researchers with a novel resource to tackle existing challenges. “For the past 15 years, scientists could only work on a single hESC state. We now provide a novel cell state for all hESC applications,” said Prof Ng Huck Hui. “The results from the study will open many new possibilities to study human development and disease. The 3iL hESCs will help to overcome some of the obstacles that limit the potential of pluripotent cells in regenerative medicine.”

The researchers also found that many genes which are active in blastocyst cells but inactive in hESCs were turned on again in this novel cell state. These re-activated genes also showed epigenetic differences. “Every cell has a ’memory’, the epigenome, which is a layer on top of the genome that marks active and inactive genes,” explained Dr Jonathan Göke, a bioinformatician from GIS “When we looked into the epigenome of these 3iL cells, we found that this ‘memory’ was dramatically different; the cells appeared to be partly set back to the state of the embryo.”

To demonstrate how these 3iL hESCs can be used to obtain insights into human development, Prof Ng’s team studied the regulatory system that controls these developmental genes. “Studies of basic mechanisms like gene regulation require a large number of cells,” said Dr Chan Yun Shen, co-lead author, and researcher at GIS. “This is the first time that we are able to see how these genes are potentially regulated. While additional experiments will help to fully characterize these 3iL hESCs, we can already see that they provide an unprecedented way to study early human development without the use of any blastocysts.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Novel Tumor Treatment
In the first published results from a $386,000 National Cancer Institute grant awarded earlier this year, a paper by Scott Verbridge and Rafael Davalos has been published.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
The Life Story of Stem Cells
A model analyses the development of stem cell numbers in the human body.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Tissue Engineers Recruit Cells to Make Their Own Strong Matrix
Extracellular matrix is the material that gives tissues their strength and stretch. It’s been hard to make well in the lab, but a Brown University team reports new success. The key was creating a culture environment that guided cells to make ECM themselves.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Artificial Kidney Research Gets A Boost
Development of a surgically implantable, artificial kidney — a promising alternative to kidney transplantation or dialysis for people with end-stage kidney disease — has received a $6 million boost.
Improving the Efficiency of Red Blood Cell Production
Study points to way of significantly reducing cost of laboratory-produced cells.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos